Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Stereotaxis Inc.

    AMEX: STXS · Real-Time Price · USD
    2.06
    0.04 (1.98%)
    At close: May 23, 2025, 3:59 PM
    2.07
    0.24%
    After-hours: May 23, 2025, 04:04 PM EDT
    1.98%
    Bid 1.97
    Market Cap 177.59M
    Revenue (ttm) 27.51M
    Net Income (ttm) -25.68M
    EPS (ttm) -0.31
    PE Ratio (ttm) -6.66
    Forward PE -11.91
    Analyst Strong Buy
    Ask 2.08
    Volume 143,998
    Avg. Volume (20D) 462,893
    Open 2.00
    Previous Close 2.02
    Day's Range 1.98 - 2.08
    52-Week Range 1.54 - 2.72
    Beta 1.46

    About STXS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol STXS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for STXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 months ago
    +15.14%
    Stereotaxis shares are trading higher after the co... Unlock content with Pro Subscription
    3 months ago
    +5.48%
    Stereotaxis shares are trading higher after the company received European CE Mark approval for its MAGIC aviation catheter to enhance robotics in electrophysiology.
    news image

    1 week ago · seekingalpha.com

    Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

    Stereotaxis, Inc. (NYSE:STXS ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants David Fischel - Chairman and CEO Kim Peery - Chief Financial Officer Conference Call Partic...

    news image

    1 week ago · zacks.com

    Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates

    Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.06 per share a year ago.

    news image

    1 month ago · zacks.com

    3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025

    Investing in surgical robotics stocks like ISRG, ZBH and STXS can be profitable for investors in 2025.

    news image

    2 months ago · zacks.com

    Stereotaxis Jumps 15% on NVIDIA's AI-Driven Collaboration: Is It a Buy Now?

    The collaboration, highlighted at NVIDIA's GTC conference, aims to integrate artificial intelligence into surgical robotics, potentially enhancing Stereotaxis' technological capabilities.

    news image

    2 months ago · zacks.com

    Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA Submission

    STXS submits MAGiC Sweep, the first robotically navigated high-density EP mapping catheter for FDA clearance, marking a milestone in cardiac arrhythmia treatment.

    news image

    2 months ago · seekingalpha.com

    Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

    I addressed the bearish concerns some investors have. Management's conservative 2025 sales guidance set beatable targets, focusing on the existing system backlog and MAGiC usage in Europe. MAGiC Sweep...

    news image

    2 months ago · zacks.com

    STXS Stock Tumbles Despite EMAGIN Catheter Submission for Approval

    Stereotaxis submits EMAGIN 5F, a robotic catheter, for regulatory clearance.

    news image

    2 months ago · zacks.com

    Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

    Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.07 per share a year ago.

    Add to Watchlist